Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Diseases, Bacterial | 2 | 2020 | 66 | 1.310 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2023 | 134 | 0.800 |
Why?
|
| Myasthenia Gravis | 1 | 2023 | 199 | 0.760 |
Why?
|
| Lymphoma, T-Cell | 1 | 2023 | 299 | 0.760 |
Why?
|
| Myositis | 1 | 2023 | 251 | 0.740 |
Why?
|
| Gram-Positive Bacteria | 1 | 2020 | 184 | 0.680 |
Why?
|
| Gram-Negative Bacteria | 1 | 2020 | 270 | 0.650 |
Why?
|
| Paronychia | 1 | 2018 | 11 | 0.650 |
Why?
|
| Myocarditis | 1 | 2023 | 771 | 0.530 |
Why?
|
| Fungi | 1 | 2018 | 327 | 0.510 |
Why?
|
| Skin | 2 | 2020 | 4364 | 0.350 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2008 | 22 | 0.320 |
Why?
|
| Cyclophilin A | 1 | 2008 | 57 | 0.310 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 53 | 0.310 |
Why?
|
| Cytosine Deaminase | 1 | 2007 | 68 | 0.300 |
Why?
|
| Bacteria | 1 | 2018 | 2114 | 0.290 |
Why?
|
| Retroviridae | 1 | 2008 | 914 | 0.260 |
Why?
|
| Skin Neoplasms | 2 | 2022 | 5686 | 0.240 |
Why?
|
| Scleroderma, Localized | 1 | 2023 | 79 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7181 | 0.200 |
Why?
|
| Macaca mulatta | 1 | 2007 | 2375 | 0.190 |
Why?
|
| Paget Disease, Extramammary | 1 | 2021 | 45 | 0.190 |
Why?
|
| Aspergillus flavus | 1 | 2020 | 14 | 0.190 |
Why?
|
| Genital Neoplasms, Male | 1 | 2021 | 74 | 0.190 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2022 | 207 | 0.180 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1940 | 0.170 |
Why?
|
| Skin Care | 1 | 2018 | 49 | 0.160 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2022 | 523 | 0.160 |
Why?
|
| Administration, Topical | 1 | 2020 | 690 | 0.160 |
Why?
|
| Dermatomycoses | 1 | 2018 | 45 | 0.160 |
Why?
|
| HIV-1 | 4 | 2008 | 6939 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2018 | 624 | 0.130 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2017 | 120 | 0.130 |
Why?
|
| Primates | 2 | 2008 | 545 | 0.130 |
Why?
|
| Taxoids | 1 | 2018 | 666 | 0.120 |
Why?
|
| Skin Diseases | 1 | 2022 | 1065 | 0.120 |
Why?
|
| Brachytherapy | 1 | 2021 | 1248 | 0.110 |
Why?
|
| Infant, Premature, Diseases | 1 | 2018 | 706 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2020 | 3913 | 0.110 |
Why?
|
| Dermatology | 1 | 2022 | 872 | 0.100 |
Why?
|
| Paclitaxel | 1 | 2018 | 1708 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 20822 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6489 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2017 | 1411 | 0.080 |
Why?
|
| Lentiviruses, Primate | 1 | 2008 | 7 | 0.080 |
Why?
|
| Macaca nemestrina | 1 | 2008 | 23 | 0.080 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2008 | 13 | 0.080 |
Why?
|
| Aotidae | 1 | 2008 | 59 | 0.080 |
Why?
|
| Polynucleotide 5'-Hydroxyl-Kinase | 1 | 2007 | 8 | 0.080 |
Why?
|
| Gene Products, vif | 1 | 2007 | 33 | 0.080 |
Why?
|
| DNA Repair Enzymes | 1 | 2009 | 349 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 437 | 0.070 |
Why?
|
| Disease Outbreaks | 1 | 2017 | 1772 | 0.070 |
Why?
|
| Retroelements | 1 | 2008 | 164 | 0.070 |
Why?
|
| Species Specificity | 2 | 2008 | 2478 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2256 | 0.070 |
Why?
|
| Virus Assembly | 1 | 2006 | 144 | 0.070 |
Why?
|
| Capsid | 1 | 2008 | 436 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2023 | 77449 | 0.060 |
Why?
|
| Capsid Proteins | 1 | 2008 | 479 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13102 | 0.060 |
Why?
|
| Pyrroles | 1 | 2009 | 1146 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2017 | 5102 | 0.050 |
Why?
|
| DNA Repair | 2 | 2009 | 2046 | 0.050 |
Why?
|
| Piperidines | 1 | 2009 | 1602 | 0.050 |
Why?
|
| Humans | 14 | 2023 | 744343 | 0.050 |
Why?
|
| Virus Replication | 1 | 2007 | 2534 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 13815 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3798 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 1 | 2018 | 180 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2006 | 3748 | 0.040 |
Why?
|
| Cell Line | 2 | 2008 | 15997 | 0.030 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2009 | 401 | 0.030 |
Why?
|
| Puerto Rico | 1 | 2017 | 356 | 0.030 |
Why?
|
| Protein Binding | 1 | 2008 | 9386 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 5172 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2017 | 607 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 6103 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 21683 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 1254 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2022 | 2266 | 0.020 |
Why?
|
| Female | 2 | 2020 | 380194 | 0.020 |
Why?
|
| Photoelectron Spectroscopy | 1 | 2009 | 12 | 0.020 |
Why?
|
| DNA Polymerase beta | 1 | 2009 | 20 | 0.020 |
Why?
|
| DNA Ligases | 1 | 2009 | 80 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9648 | 0.020 |
Why?
|
| Middle Aged | 2 | 2022 | 213383 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2022 | 4386 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2009 | 354 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2018 | 2044 | 0.020 |
Why?
|
| Etoposide | 1 | 2009 | 641 | 0.020 |
Why?
|
| 2-Naphthylamine | 1 | 2007 | 23 | 0.020 |
Why?
|
| Forecasting | 1 | 2017 | 2951 | 0.020 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2009 | 358 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 2008 | 878 | 0.020 |
Why?
|
| Animals | 3 | 2008 | 168757 | 0.020 |
Why?
|
| Xenopus Proteins | 1 | 2009 | 433 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 3610 | 0.020 |
Why?
|
| Camptothecin | 1 | 2009 | 576 | 0.020 |
Why?
|
| Cricetulus | 1 | 2008 | 816 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 1723 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2006 | 337 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2017 | 2616 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 563 | 0.020 |
Why?
|
| Male | 2 | 2021 | 350118 | 0.020 |
Why?
|
| CHO Cells | 1 | 2008 | 1406 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 712 | 0.020 |
Why?
|
| Virion | 1 | 2006 | 433 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 18111 | 0.020 |
Why?
|
| Cricetinae | 1 | 2008 | 2472 | 0.020 |
Why?
|
| Endosomes | 1 | 2006 | 520 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 2025 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2007 | 1801 | 0.010 |
Why?
|
| Endocytosis | 1 | 2006 | 985 | 0.010 |
Why?
|
| Biological Transport | 1 | 2006 | 2118 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6314 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2009 | 4011 | 0.010 |
Why?
|
| Microtubules | 1 | 2006 | 1090 | 0.010 |
Why?
|
| Binding Sites | 1 | 2009 | 6114 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5179 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2007 | 3846 | 0.010 |
Why?
|
| Cell Survival | 1 | 2009 | 5882 | 0.010 |
Why?
|
| Kinetics | 1 | 2007 | 6473 | 0.010 |
Why?
|
| Actins | 1 | 2006 | 2121 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2008 | 1861 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 25625 | 0.010 |
Why?
|
| Incidence | 1 | 2017 | 20947 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6622 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2008 | 5974 | 0.010 |
Why?
|
| DNA Damage | 1 | 2007 | 2432 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 35136 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 12797 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2022 | 63114 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 5655 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 19229 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 9583 | 0.010 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_